AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($399.47 B vs $293.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRK | ABBV |
|---|---|---|
| Market cap | $293.16 B | $399.47 B |
| US-listed rank | #44 | #28 |
| Revenue (latest FY) | $65.01B | $61.16B |
| Net income (latest FY) | $18.25B | $4.23B |
| Net margin | 28.1% | 6.9% |
| P/E (trailing FY) | 16.1 | 94.5 |
| SEC filings | 996 | 1,008 |
AbbVie Inc. is 1.4x more valuable than Merck & Co., Inc. by market capitalization ($399.47 B vs $293.16 B).
In their latest fiscal years, Merck & Co., Inc. reported $65.01B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Merck & Co., Inc. and AbbVie Inc., or browse the full rankings.